Nuclear Medicine and Biology
Volume 35, Issue 4 , Pages 433-440 , May 2008

Investigation of four 99mTc-labeled bacteriophages for infection-specific imaging

Received 17 October 2007 ,Revised 28 January 2008 ,Accepted 28 February 2008.

References 

  1. Vinjamuri S, Hall AV, Solanki KK, Bomanji J, Siroj O, O'Shaughnessy E, et al. Comparison of 99mTc-infecton imaging with radiolabeled white-cell imaging in the evaluation of bacterial infection. Lancet. 1996;347:233–235
  2. Welling MM, Lupetti A, Balter HS, Lanzzeri S, Souto B, Rey AM, et al. 99mTc-labeled antimicrobial peptides for detection of bacterial and Candida albicans infections. J Nucl Med. 2001;42:788–794
  3. Akhtar MS, Iqbal J, Khan MA, Irfanullah J, Jehangir M, Kha B, et al. 99mTc-labeled antimicrobial peptide ubiquicidin (29–41) accumulates less in Escherichia coli infections than in Staphylococcus aureus infection. J Nucl Med. 2004;45:849–856
  4. Welling MM, Paulusma-Annema A, Balter HS, Pauwels EK, Nibbering PH. Technetium-99m labeled antimicrobial peptides discriminate between bacterial infections and sterile inflammations. Eur J Nucl Med. 2000;27:292–301
  5. Tsopelas C, Penglis S, Ruszkiewicz A, Bartholomeusz FD. 99mTc-alafosfalin: an antibiotic peptide infection imaging agent. Nucl Med Biol. 2003;30:169–175
  6. Welling MM, Nibbering PH, Paulusma-Annema A, Hiemstra PS, Pauwels EK, Calame W. Imaging of bacterial infections with 99mTc-labeled human neutrophil peptide-1. J Nucl Med. 1999;40:2073–2080
  7. Rusckowski M, Gupta S, Liu G, Dou S, Hnatowich DJ. Investigations of a 99mTc-labeled bacteriophage as a potential infection-specific imaging agent. J Nucl Med. 2004;45:1201–1208
  8. Winnard P, Chang F, Rusckowski M, Mardirossian G, Hnatowich DJ. Preparation and use of NHS-MAG3 for technetium-99m labeling of DNA. Nucl Med Biol. 1997;24:425–432
  9. Adams MH. Bacteriophages. New York (NY): Intersciences Publishers. Inc.; 1959;
  10. In:  Denhardt DT,  Dressler D,  Ray DS editor. The single stranded DNA phages. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory; 1978;p. 605–625
  11. Hnatowich DJ, Qu T, Chang F, Ley AC, Ladner RC, Rusckowski M. Labeling peptides with 99mTc using an NHS-MAG3 bifunctional chelator. J Nucl Med. 1998;39:56–64
  12. Helenius A, McCaslin DR, Fries E, Tanford C. Properties of detergents. Methods Enzymol. 1979;56:734–749
  13. Contag CH, Contag PR, Mullins JI, Spilman SD, Stevenson DK, Benaron DA. Photonic detection of bacterial pathogens in living hosts. Mol Microbiol. 1995;18:593–603
  14. Burns-Guydish SM, Olomu IN, Zhao H, Wong RJ, Stevenson DK, Contag CH. Monitoring age-related susceptibility of young mice to oral Salmonella enterica serovar Typhimurium infection using an in vivo murine model. Pediatr Res. 2005;58:153–158
  15. Kadurugamuwa JL, Sin L, Albert E, Yu J, Francis K, DeBoer M, et al. Direct continuous method for monitoring biofilm infection in a mouse model. Infect Immun. 2003;71:882–890
  16. Kadurugamuwa JL, Sin LV, Yu J, Francis KP, Kimura R, Purchio T, et al. Rapid direct method for monitoring antibiotics in a mouse model of bacterial biofilm infection. Antimicrob Agents Chemother. 2003;47:3130–3137

PII: S0969-8051(08)00061-9

doi: 10.1016/j.nucmedbio.2008.02.011

Nuclear Medicine and Biology
Volume 35, Issue 4 , Pages 433-440 , May 2008

Article Tools

* Image Usage & Resolution